Clinical Trials

Private medical technology company, Bluegrass Vascular Technologies emphasizing on developing innovating lifesaving devices and methods for vascular access asserted the enrollment of…
Read More...

Company developing intratumoral cancer immunotherapies, OncoSec Medical claimed the observations of preliminary Clinical trial study related to its OMS-1140 ImmunoPulse 1L-12 in…
Read More...

A Gilead Company, Kite ventures into Clinical Trial collaboration with  Pfizer, enabling assessment of the efficacy of the investigational combination of Yescarta (axicabtagene…
Read More...

Marina Biotech, a biopharmaceutical company committed to the development and commercialization of advanced therapeutics for hypertension, arthritis, pain and oncology embarked on a…
Read More...

A biotech company that designs and develops virus-based  immunotherapies, Transgene confirms dosing the first patient in  a Phase 1 Clinical Trial in China, evaluating T101, therapeutic…
Read More...

Ipsen bio-pharmaceuticals set to present five new sub-analyses of the pivotal Phase 3 NAPOLI-1 trial at this year's American Society of Clinical Oncology’s Gastrointestinal Cancer…
Read More...

MiMedx Group confirmed the enrollment of first patients in the Company's Phase 3 Investigational New Drug (IND) Clinical Trial for MiMedx's micronized amniotic tissue, AmnioFix…
Read More...

GC Pharma, a South Korean biopharmaceutical company affirmed that it will conduct Phase 2/3 clinical trial for GC1102, the company's investigational recombinant hepatitis B immune…
Read More...

CompleWare and YPrime  partner to offer enhanced service offerings involving Clinical Trials, electronic clinical outcome assessment (eCOA) technology and interactive response…
Read More...

In a bid to ensure transparency and clarity in their drug approval decisions,  U.S FDA Commissioner Scott Gottlieb endeavors to undertake new drug innovation and Scientific progress by…
Read More...

Ophthotech Corporation enrolled first patient in the Phase 2b randomized, double-masked, sham-controlled clinical trial assessing the efficacy and safety of Zimura complement C5…
Read More...

Ipsen and Exelixis declared results of Phase 3 CELESTIAL trial in  patients formerly treated with advanced heptacellular carcinoma. In CELESTIAL, cabozantinib provided a statistically…
Read More...

Utilizing advanced analytics to offer workflow solutions and apps that advocate support solutions paving way for undisputed integration and analysis of in-vivo and in-vitro data, …
Read More...

Global biotech company committed to delivering transformative therapies to patients with orphan dermatologic and other underserved conditions, Castle Creek Pharmaceuticals confirmed…
Read More...

Celgene Corporation and Impact Biomedicinessigned and agreement that entails acquisition of Impact Biomedicines enabling development of fedratinib  for myelofibrosis and polycythemia…
Read More...

Following the league of leading in the markets of  clinical research organizations, Optimapharm obtained Czech CRO company MKS research. Following the acquisition , Optimapharm will…
Read More...

Clinical Biopharmaceutical Company Rgenix declared the Clinical and pre-Clinical results by research collaborators at Rgenix and Rockefeller University disclosing that Liver-X…
Read More...

This is to be brought to notice that WaveForm Technologies has successfully completed its four clinical Trials for its proprietary continuous glucose monitoring system. Patients are…
Read More...

The Medical Ethical Review Committee sought the Xcede Patch clinical trial dossier to initiate first-in-human clinical trial that eyes the treatment of up to 30 patients encountering…
Read More...

After the Bone, Reproductive and Urologic Drugs Advisory Committee ("BRUDAC") of the U.S. Food and Drug Administration ("FDA") voted six in favor and thirteen against the benefit/risk…
Read More...